Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice
Abstract Aim The anticoagulation effect of warfarin is usually evaluated by percentage of time in therapeutic range (PTTR), which is negatively correlated with the risk of warfarin adverse reactions. This study aimed to explore the effects of genetic and nongenetic factors on anticoagulation efficac...
Main Authors: | Bao Sun, Siqing Ma, Feiyan Xiao, Jianquan Luo, Mouze Liu, Wenhui Liu, Zhiying Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-023-03321-9 |
Similar Items
-
Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
by: Theodore J. Wigle, et al.
Published: (2017-12-01) -
The Influence of Ethnicity on Warfarin Dosage Requirements in the Chilean Population
by: Valeska Subiabre, MsCs, et al.
Published: (2015-12-01) -
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
by: Assaf Gottlieb, et al.
Published: (2017-11-01) -
Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
by: Salih Kilic, et al.
Published: (2018-01-01) -
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01)